Skip to main content
Loading

Mercy BioAnalytics

February 26, 2024
Diagnostics
Mercy BioAnalytics
Mercy BioAnalytics is a pre-commercial diagnostics company on a mission to save lives and relieve suffering through the early detection of cancer. We are developing ,broadly accessible, inexpensive, blood-based screening tests, initially focused on two critical areas of unmet need: detection of lung and ovarian cancer in patients who are at higher risk. At Mercy, we believe all those at higher risk for developing cancer should have access to high performing, affordable screening tests, and are committed to advancing our innovative portfolio of tests towards global clinical impact.
Testimonials

Conference Sponsors


 

Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.

SIGN UP